Status:
COMPLETED
Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms
Lead Sponsor:
University of Maryland, College Park
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Conditions:
Cigarette Smoking
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Depression related vulnerabilities are highly comorbid with smoking behavior and dramatically reduce cessation rates among both community and clinical samples. Previous research has examined the effic...
Detailed Description
This will be a Stage II randomized control trial to examine the efficacy of behavioral activation treatment for smoking (BATS) vs. standard smoking cessation treatment (ST). We will recruit 200 smoker...
Eligibility Criteria
Inclusion
- Between 18 and 65 years of age
- A regular smoker for at least one year
- Currently smoking an average of at least 10 cigarettes per day
- Want to quit smoking
- Report current elevated depressive symptoms
Exclusion
- Current Axis I disorder
- Psychoactive substance dependence (excluding nicotine dependence) within the past 6 months
- Current use of psychotropic medication or participation in any form of psychotherapy
- A history of significant medical condition (e.g., cardiovascular , neurological, gastrointestinal), pregnancy and/or breast feeding, or other systemic illness
- Current use of any pharmacotherapy for smoking cessation not provided by the researchers during the quit attempt
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT01199380
Start Date
September 1 2010
End Date
May 1 2016
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland, College Park
College Park, Maryland, United States, 20742